Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Bayer AHA heart attack/stroke risk package insert available during first quarter.

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

BAYER HEART ATTACK/STROKE RISK QUESTIONNAIRE is included in specially marked packages of Bayer Genuine Aspirin that are expected to be sold during the first quarter. Approximately 750,000 copies of the risk assessment brochure were included in Bayer packaging. Authored by the American Heart Association but funded and formatted by Bayer, the questionnaire is entitled "Are you at risk of a heart or brain attack? Take this quick quiz to find out!"

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

US FDA Transparency Win: Sponsors Know More Product-Specific Guidances Coming, Requests Fall

Cost Of Reviewing Drugs With AI Is ‘Prohibitive’ For US FDA

Project 5 In 5: US FDA Oncology Office Seeks Pragmatic Trial Proposals From Clinicians, Patients

Global Pharma Guidance Tracker – April 2024

See All
UsernamePublicRestriction

Register

PS088141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By